Daniela Dwyer Foundation
Back to News
MediaNovember 2025

7NEWS Interview: Advancing Brain Cancer Research

Channel 7NEWS visited the Grey Matter Gala to sit down with DDF Director Taylor Bow and Professor Sudha Rao from QIMR Berghofer — shining a national spotlight on groundbreaking liquid biopsy research.

As part of the recent Grey Matter Gala, Channel 7NEWS visited the Perth Convention and Exhibition Centre for an exclusive interview with Daniela Dwyer Foundation Director, Taylor Bow, and Professor Sudha Rao from QIMR Berghofer.

The segment highlights Professor Rao's groundbreaking work developing a new liquid biopsy technology that has the potential to transform how brain cancer is detected and monitored — offering hope for earlier diagnosis and more effective treatment.

Taylor and Professor Rao also discussed the vital role of community support and funding from the Daniela Dwyer Foundation in accelerating this important research.

The Research Making Headlines

The Daniela Dwyer Foundation is proud to champion Professor Rao's innovative research. Our funding has helped drive this world-first liquid biopsy technology to its current clinical trial, and eventual national use.

With continued support, this work has the potential to give doctors the ability to track brain cancer progression through a simple blood test — sparing patients from invasive procedures and allowing for faster, more personalised treatment decisions.

“This technology has the potential to transform how brain cancer is detected and monitored — offering real hope for patients and families.”

— Professor Sudha Rao, QIMR Berghofer

Why This Matters

Brain cancer remains one of the most underfunded and devastating cancers in Australia. Survival rates have barely changed in 30 years. Media coverage like this 7NEWS segment plays a critical role in raising public awareness and inspiring the community support that makes research like Professor Rao's possible.

Every event, every donation, and every conversation helps bring this technology one step closer to becoming standard care for patients across Australia.

$250,000

Total research funding to date

Phase 1

Clinical trial now underway

Help us keep the momentum going

Your donation directly funds life-saving brain cancer research. All donations over $2 are tax-deductible.